- Home
- CTMX vs SCWO Comparison
CTMX vs SCWO Comparison
Compare CTMX & SCWO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTMX
- SCWO
- Stock Information
- Founded
- CTMX 2008
- SCWO 2021
- Country
- CTMX United States
- SCWO United States
- Employees
- CTMX N/A
- SCWO N/A
- Industry
- CTMX Biotechnology: Pharmaceutical Preparations
- SCWO Environmental Services
- Sector
- CTMX Health Care
- SCWO Utilities
- Exchange
- CTMX Nasdaq
- SCWO Nasdaq
- Market Cap
- CTMX 62.3M
- SCWO 64.3M
- IPO Year
- CTMX 2015
- SCWO N/A
- Fundamental
- Price
- CTMX $0.60
- SCWO $0.37
- Analyst Decision
- CTMX Buy
- SCWO
- Analyst Count
- CTMX 6
- SCWO 0
- Target Price
- CTMX $5.77
- SCWO N/A
- AVG Volume (30 Days)
- CTMX 3.5M
- SCWO 289.1K
- Earning Date
- CTMX 03-06-2025
- SCWO 03-28-2025
- Dividend Yield
- CTMX N/A
- SCWO N/A
- EPS Growth
- CTMX N/A
- SCWO N/A
- EPS
- CTMX 0.38
- SCWO N/A
- Revenue
- CTMX $138,103,000.00
- SCWO $313,930.00
- Revenue This Year
- CTMX N/A
- SCWO N/A
- Revenue Next Year
- CTMX N/A
- SCWO $5,180.00
- P/E Ratio
- CTMX $1.56
- SCWO N/A
- Revenue Growth
- CTMX 36.45
- SCWO N/A
- 52 Week Low
- CTMX $0.57
- SCWO $0.30
- 52 Week High
- CTMX $5.85
- SCWO $1.99
- Technical
- Relative Strength Index (RSI)
- CTMX 29.59
- SCWO 41.29
- Support Level
- CTMX $0.60
- SCWO $0.30
- Resistance Level
- CTMX $0.78
- SCWO $0.37
- Average True Range (ATR)
- CTMX 0.06
- SCWO 0.03
- MACD
- CTMX -0.00
- SCWO 0.01
- Stochastic Oscillator
- CTMX 4.17
- SCWO 66.22
About CTMX CytomX Therapeutics Inc.
CytomX Therapeutics Inc is an oncology-focused biopharmaceutical company that is operating in the United States. It is engaged in developing antibody therapeutics based on probody technology platforms. The company's probody technology platform creates proprietary cancer immunotherapies against clinically-validated targets and develops cancer therapeutics. Probody therapeutics are designed to take advantage of conditions in the tumor microenvironment to enhance the tumor-targeting features of an antibody and reduce drug activity in healthy tissues.
About SCWO 374Water Inc.
374Water Inc offers a technology that transforms wet wastes such as sewage sludge, biosolids, food waste, hazardous and non-hazardous waste, and forever chemicals (e.g., PFAS) into recoverable resources by focusing on waste as a valuable resource for water, energy, and minerals. The business activities of the company include manufacturing processes and waste recycling and treatment processes, which currently involve the use, treatment, storage, transfer, handling and/or disposal of hazardous materials, chemicals and wastes.